Skip to content

The effects of peptide on BMI in adults: A randomized, double-blind, placebo-controlled study

The effects of peptide on BMI in adults: A randomized, double-blind, placebo-controlled study - The effects of peptide on BMI in adults: A randomized, double-blind, placebo-controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047856
Enrollment
200
Registered
2022-05-30
Start date
2022-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Ingestion of the test food for 12 weeks. Ingestion of the test food for 12 weeks.

Sponsors

Yamaguchi Comprehensive Examination Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Subjects aged 20-64 years 2) Subjects whose BMIs are >= 25 and < 30.

Exclusion criteria

Exclusion criteria: 1) Subjects who are under treatment or have a history of serious disorders in Malignant tumor, liver, kidney, heart, lung, gastro-intestine, blood, endocrine system, or metabolic system etc. 2) Subjects who regularly use foods and supplements that may affect obesity, hyperlipidemia, lipid metabolism and uric acid levels. 3) Subjects who have drug allergies or severe food allergies, and/or a previous medical history of such allergies. 4) Subjects who are pregnant, lactation, or planning to become pregnant. 5) Subjects drink alcohol polydipsia (pure alcohol equivalent more than 60 g/day) 6) Subjects who have drug addiction or alcohol addiction, and/or these medical history. 7) Subjects who participated in other clinical trials or participated in clinical trials of other drugs or foods within one month before the date of consent acquisition. 8) Subjects who are judged inappropriate to this trial by the investigator.

Design outcomes

Primary

MeasureTime frame
BMI

Secondary

MeasureTime frame
1) Waist circumference 2) Body fat percentage 3) Body fat mass 4) Muscle mass 5) Triglyceride 6) Serum uric acid level 7) 8-OHdG (oxidative stress) 8) Japanese version of POMS-2 (fatigue) 9) VAS (fatigue)

Countries

Japan

Contacts

Public ContactShinji Nakamura

Yamaguchi Health Lab General manager

info@yamaguchi-hl.com083-976-4095

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026